MOESM1 of Effects of 6-month eicosapentaenoic acid treatment on postprandial hyperglycemia, hyperlipidemia, insulin secretion ability, and concomitant endothelial dysfunction among newly-diagnosed impaired glucose metabolism patients with coronary artery disease. An open label, single blinded, prospective randomized controlled trial
2016-08-26T05:00:00Z (GMT) by
Additional file 1: Table S1. Multiple regression analysis for predicting incremental glucose peak improvement.